Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guiqihuoxue Capsules for cervical spondylosis
ChiCTR2200062439Phase 4Not yet recruiting
- Sponsor
- Second Hospital of Shandong University
- Start
- Aug 2022
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of guiqihuoxue in cervical osteoarthritis (2 arms), sponsored by Second Hospital of Shandong University. Primary endpoints: Japanese Orthopaedic Association score (JOA), Neck Disability Index (NDI) and 1 more. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
guiqihuoxue
03
Conditions
cervical osteoarthritis
Beyond the preview
Go deeper on ChiCTR2200062439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062439.